Spectrochimica Acta - Part A: Molecular And Biomolecular Spectroscopy impact factor, indexing, ranking (2024)


spectrochimica

Aim and Scope

The Spectrochimica Acta - Part A: Molecular And Biomolecular Spectroscopy is a research journal that publishes research related to Chemistry; Physics and Astronomy. This journal is published by the Elsevier. The ISSN of this journal is 13861425. Based on the Scopus data, the SCImago Journal Rank (SJR) of spectrochimica acta - part a: molecular and biomolecular spectroscopy is 0.635.

Also, please check the following important details about spectrochimica acta - part a: molecular and biomolecular spectroscopy: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Spectrochimica Acta - Part A: Molecular And Biomolecular Spectroscopy Ranking

Journal Rank: 8036
SJR (SCImago Journal Rank): 0.635
Quartile: Q2
H-Index: 145

The SJR (SCImago Journal Rank) measures citations weighted by prestige. It is useful for comparing journals within the same field, and forms the basis of the subject category ranking. A journal SJR indicator is a numeric value representing the average number of weighted citations received during a selected year per document published in that journal during the previous three years, as indexed by Scopus. Higher SJR indicator values are meant to indicate greater journal prestige. SJR is developed by the Scimago Lab, originated from a research group at University of Granada. Q1 journals are cited more often and by more prestigious journals than those in the other quartiles.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

CiteScore of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal. This journal evaluation metric was launched in December 2016 by Elsevier as an alternative to the generally used JCR impact factors (calculated by Clarivate). CiteScore is based on the citations recorded in the Scopus database rather than in JCR, and those citations are collected for articles published in the preceding four years instead of two or five.

Source Normalized Impact per Paper (SNIP) is calculated annually from Scopus data. It is a sophisticated metric that intrinsically accounts for field-specific differences in citation practices.



Important Metrics

Journal Title: Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
Publisher: Elsevier
ISSN: 13861425
Type: journal
Journal Scope: Chemistry; Physics and Astronomy
Country: Netherlands
H-Index: 145
SJR: 0.635
Quartile: Analytical Chemistry (Q2); Atomic and Molecular Physics, and Optics (Q2); Instrumentation (Q2); Spectroscopy (Q2)

Indexing

The spectrochimica acta - part a: molecular and biomolecular spectroscopy is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Quartile

The latest Quartile of spectrochimica acta - part a: molecular and biomolecular spectroscopy is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Spectrochimica Acta - Part A: Molecular And Biomolecular Spectroscopy?

If your research is related to Chemistry; Physics and Astronomy, then visit the official website of spectrochimica acta - part a: molecular and biomolecular spectroscopy and send your manuscript.

Tips for publishing in Spectrochimica Acta - Part A: Molecular And Biomolecular Spectroscopy:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • It is published by Elsevier.
  • The journal is indexed in UGC CARE, Scopus, PubMed.
  • The (SJR) SCImago Journal Rank is 0.635.

Sources: spectrochimica acta - part a: molecular and biomolecular spectroscopy







SIMILIAR JOURNALS


MODERN PHYSICS LETTERS A

ISSN: 0217-7323
Publisher: WORLD SCIENTIFIC PUBL CO PTE LTD

PARTICLES

ISSN:
Publisher: MDPI

CLASSICAL AND QUANTUM GRAVITY

ISSN: 0264-9381
Publisher: IOP PUBLISHING LTD

GENERAL RELATIVITY AND GRAVITATION

ISSN: 0001-7701
Publisher: SPRINGER/PLENUM PUBLISHERS

PHYSICS LETTERS B

ISSN: 0370-2693
Publisher: ELSEVIER

ADVANCED FUNCTIONAL MATERIALS

ISSN: 1616-301X
Publisher: WILEY-V C H VERLAG GMBH

ADVANCED MATERIALS

ISSN: 0935-9648
Publisher: WILEY-V C H VERLAG GMBH

NANO LETTERS

ISSN: 1530-6984
Publisher: AMER CHEMICAL SOC

SMALL

ISSN: 1613-6810
Publisher: WILEY-V C H VERLAG GMBH

SCIENTIA SINICA-PHYSICA MECHANICA & ASTRONOMICA

ISSN: 1674-7275
Publisher: SCIENCE PRESS

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.